Loading...
The early end to the Strategic Timing of Antiretroviral Treatment study proves that it's better to be on HIV treatment than to wait, even for those with normal CD4-cell counts and no symptoms. Why was deferring treatment a common strategy? In HIV and ID Observations, Dr. Paul Sax lists some reasons, most of which are irrelevant or have been disproven over time.